|
Identification of Resistance Mechanisms and Novel Therapeutic Strategies in Tyrosine Kinase Inhibitor Resistant FLT3/ITD Acute Myeloid Leukemia |
Fred Hutchinson Cancer Research Center |
Northwestern Mutual Foundation |
|
Development of Targeted DNA-damaging Therapy for ATRX-deficient Pediatric Glioblastoma |
University of Michigan |
Northwestern Mutual Foundation |
|
A Developmental Model to Characterize the Epigenetic Origins of the Retinoblastoma Tumor Initiating Cell |
The Johns Hopkins University School of Medicine |
Northwestern Mutual Foundation |
|
B-lapachone as a Novel Targeted Therapy for ATRTs and other Pediatric Cancers
|
University of Texas Southwestern Medical Center |
Cure4Cam Childhood Cancer Foundation |
|
Neural Stem Cell-Mediated Drug Delivery for Targeted Treatment of Medulloblastoma
|
Beckman Research Institute of City of Hope |
I Care I Cure |
|
Development of a Novel Mer Tyrosine Kinase Inhibitor for Treatment of ALL |
University of Colorado Denver |
Cure4Cam Childhood Cancer Foundation, I Care I Cure |
|
Development of a Novel Mer Tyrosine Kinase Inhibitor for Treatment of ALL |
University of Colorado Denver |
Cure4Cam Childhood Cancer Foundation, I Care I Cure |
|
Development of a Pharmacodynamic Marker of EWS-FLI1 Activity to Aid in the Clinical Translation of Targeted Therapies for Ewing sarcoma |
Van Andel Research Institute |
I Care I Cure |
|
Children's Hospital Colorado Experimental Therapeutics Program |
Children’s Hospital Colorado |
Northwestern Mutual Foundation |
|
Reactivating Apoptosis in Refractory Pediatric Cancer by Molecular Inhibition of MCL-1 |
Dana-Farber Cancer Institute |
Cure4Cam Childhood Cancer Foundation |
